Equities

Avinger Inc

AVGR:NAQ

Avinger Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.9552
  • Today's Change-0.040 / -3.99%
  • Shares traded163.13k
  • 1 Year change-93.07%
  • Beta1.1768
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5.281519
Total Receivables, Net1.011.061.39
Total Inventory5.304.974.60
Prepaid expenses0.580.360.30
Other current assets, total------
Total current assets122126
Property, plant & equipment, net1.592.903.27
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.020.310.42
Total assets142429
LIABILITIES
Accounts payable0.780.631.39
Accrued expenses4.063.153.31
Notes payable/short-term debt000
Current portion long-term debt/capital leases14140
Other current liabilities, total0.17----
Total current liabilities19184.71
Total long term debt0012
Total debt141412
Deferred income tax------
Minority interest------
Other liabilities, total0.672.102.77
Total liabilities202020
SHAREHOLDERS EQUITY
Common stock0.000.010.10
Additional paid-in capital414407394
Retained earnings (accumulated deficit)(421)(402)(385)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity(6.2)4.159.72
Total liabilities & shareholders' equity142429
Total common shares outstanding1.280.520.32
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.